Examining the Economic Viability of Bladder Scanners for Healthcare Providers

 


What is a Bladder Scanner?

Bladder scanners are medical devices used for non-invasive measurement of urine volume in the bladder. They play a vital role in healthcare settings, especially in cases of urinary retention, incontinence, or other urinary tract abnormalities. The bladder scanners market is expected to grow significantly in the coming years, owing to the increasing prevalence of urinary disorders and the rising adoption of non-invasive medical procedures.

Bladder Scanners Market Size and Forecast

According to a report, the global bladder scanners market size was valued at USD 158 million in 2020 and is expected to reach USD 219.4 million by 2025, growing at a CAGR of 6.8% during the forecast period.

Bladder Scanners Key Companies

Some of the key companies in the bladder scanners market include C. R. Bard, Inc., Verathon, Inc., Signostics Medical Inc., dBMEDx, Inc., SRS Medical Systems, Inc., Vitacon US, LLC, MCube Technology Co., Ltd., Laborie Medical Technologies, and dMdx Diagnostic.

Bladder Scanners Market Trends

The bladder scanners market is witnessing several trends that are expected to shape its growth in the coming years. One of the major trends in the bladder scanners market is the development of portable and handheld bladder scanners that are easy to use and provide accurate results. These devices are gaining popularity among healthcare professionals, as they offer convenience and ease of use.

Another trend is the increasing adoption of 3D ultrasound technology in bladder scanners. 3D ultrasound allows for a more comprehensive view of the bladder and helps in accurate measurement of urine volume. This technology is expected to drive the growth of the bladder scanners market in the coming years.

Bladder Scanners Pipeline Therapies

Several pipeline therapies are under development for the treatment of urinary disorders, including bladder scanners. One such therapy is the use of virtual reality (VR) technology for bladder training. VR-based bladder training has shown promising results in clinical trials and is expected to revolutionize the treatment of urinary incontinence and other urinary disorders.

Market Drivers and Barriers

The bladder scanners market is driven by several factors, including the increasing prevalence of urinary disorders, rising geriatric population, and the growing demand for non-invasive medical procedures. However, the high cost of bladder scanners and the lack of skilled healthcare professionals to operate them are some of the major barriers to the growth of the bladder scanners market.

Bladder Scanners Upcoming Trends

The bladder scanners market is expected to witness several upcoming trends, including the development of wireless and mobile bladder scanners, the integration of artificial intelligence (AI) in bladder scanning devices, and the increasing adoption of telemedicine for the diagnosis and treatment of urinary disorders.

In conclusion, the bladder scanners market is poised for significant growth in the coming years, driven by several factors such as the increasing prevalence of urinary disorders, rising geriatric population, and the growing demand for non-invasive medical procedures. The development of portable and handheld bladder scanners, the increasing adoption of 3D ultrasound technology, and the emergence of pipeline therapies such as VR-based bladder training are some of the major trends that are expected to shape the growth of the market. However, the high cost of bladder scanners and the lack of skilled healthcare professionals to operate them remain major barriers to the growth of the bladder scanners market.


To know more about our Consulting Services, Click here: DelveInsight Healthcare Consulting


Related Reports by DelveInsight- 

scedosporium infection market | autoimmune pulmonary alveolar proteinosis market | rosai-dorfman disease market | sandhoff disease market | b-cell chronic lymphocytic leukemia market | bladder cancer market | trichomoniasis market | bile duct cancer market | resorbable vascular scaffold market | salivary gland infection market | ischemic stroke market | paget's disease market | ventricular assist devices market | vascular stents market | vascular graft devices market | bladder scanners market | b-cell non-hodgkin lymphoma market | basal cell carcinoma market | birch allergy market | vein illumination devices market


Recent Blog’s By DelveInsight:

Comments

Post a Comment

Popular posts from this blog

The Science Behind Vaccine Adjuvants: Strengthening Our Defenses

Image
  What are Vaccine Adjuvants? Vaccine adjuvants are substances added to vaccines to enhance the body’s immune response to the provided antigen. By boosting the efficacy of vaccines, adjuvants play a crucial role in providing long-lasting immunity against infectious diseases. They can help reduce the amount of antigen needed, thereby improving vaccine stability and cost-effectiveness. Types of Vaccine Adjuvants There are several types of vaccine adjuvants , each working through different mechanisms. Traditional adjuvants include aluminum salts (alum), which have been used for decades. Modern adjuvants include oil-in-water emulsions, liposomes, and saponins. Recent advancements have introduced TLR (Toll-like receptor) agonists, which stimulate specific immune pathways to enhance the vaccine's effectiveness. These include TLR3, TLR4, and TLR9 agonists, which mimic natural infection signals to elicit a stronger immune response. Vaccine Adjuvants Market Dynamics The global vaccine adju
Read more

FDA Approval Marks New Hope: Eli Lilly’s Donanemab for Alzheimer’s Disease

Image
  The Birth of a Breakthrough Eli Lilly’s groundbreaking drug, Donanemab, has recently received FDA approval, marking a significant milestone in Alzheimer’s disease treatment . This innovative therapy, designed to target and reduce amyloid plaques in the brain, offers new hope for patients battling this debilitating condition. Donanemab’s approval comes at a pivotal moment, as it represents a major advancement in the Alzheimer’s disease pipeline, promising improved outcomes for those affected. Navigating Regulatory Waters The journey of Donanemab through the regulatory landscape was complex, characterized by rigorous scrutiny and extensive clinical trials. Eli Lilly’s success in obtaining FDA approval highlights the drug’s potential to revolutionize Alzheimer’s disease therapies . This regulatory endorsement not only underscores the efficacy and safety of Donanemab but also sets a new standard for the evaluation of future treatments. Donanemab: Cost and Coverage As with many groundbre
Read more

Papilloma Market Report: Detailed Epidemiology and 2032 Forecast

Image
Papilloma is a benign tumor that arises from epithelial tissue and is often associated with the human papillomavirus (HPV). These tumors can occur in various body parts, including the skin, mucous membranes, and genital areas. Understanding the market dynamics, epidemiology, and future trends for papilloma is crucial for developing effective treatments and improving patient outcomes. Papilloma Market Insight The papilloma market is experiencing steady growth, driven by increasing awareness of HPV-related diseases and advancements in diagnostic technologies. Papilloma can lead to complications if left untreated, making early diagnosis and effective treatment essential. The market for papilloma therapies includes a range of options such as antiviral drugs, cryotherapy, and surgical interventions. The introduction of novel therapies and ongoing research into targeted treatments are expected to enhance patient outcomes and drive market growth. Papilloma Epidemiology Papilloma is relative
Read more